Stifel analysts initiated coverage on Cytokinetics shares (NASDAQ:CYTK), assigning a Buy rating and setting a price target of ...

Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the ...

Stifel analysts, led by Brian Chin, reaffirmed their Hold rating on shares of FormFactor (NASDAQ:FORM), with a steady price ...

Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...

Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...

Stifel Nicolaus analyst Cole McGill maintained a Buy rating on ioneer Limited (GSCCF – Research Report) today and set a price target of A$0.40.

Investment analysts at Stifel Canada issued their FY2024 earnings estimates for TELUS International (Cda) in a research note issued on Wednesday, January 15th. Stifel Canada analyst S. Sukumar ...

Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.

Stifel downgraded cybersecurity firm Rapid7 Inc (NASDAQ:RPD) to "Hold" from "Buy" as it trimmed its price target to $42 from $48 given a cautious outlook on the vulnerability management (VM) market.

Investment dealer Eight Capital has announced plans to wind down its operations, marking a significant shift in Canada’s ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.

Investing.com -- Stifel analysts highlighted their top small and mid-cap UK stock picks for 2025, focusing on sectors such as industrials, healthcare, and technology.